Interferon modulates neuronal activity recorded from the hypothalamus, thalamus, hippocampus, amygdala and the somatosensory cortex

Brain Research

Volumn 734, Issue 1-2, 1996, Pages 269-274

  Dafny, Nachum ^a   Prieto Gomez, Bertha ^b   Dong, Wei Qiang ^a   Reyes Vazquez, Cruz ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Interferon; Neuromodulator; Neuronal activity

Indexed keywords

RECOMBINANT ALPHA INTERFERON;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HIPPOCAMPUS; HISTOLOGY; HYPOTHALAMUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SOMATOSENSORY CORTEX; THALAMUS;

EID: 0030599184     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00650-6     Document Type: Article

References (45)

1. [1] Adams, F., Quesada, J.R. and Gutterman, J.V., Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer, J. Am. Med. Assoc., 252 (1984) 938-941.
2. 125 I-labelled mouse interferon to specific cell surface receptors, Nature, 284 (1980) 459-461.
3. [3] Aoki, N., Marajama, Y., Ohmo, Y. and Azuma, Y., Indomethacin augments inhibitory effects on interferon on lymphoproliferative response, Immunol. Lett., 7 (1984) 321-324.
4. [4] Bartlett, P.F. Pluropotential hemopoetic stem cells in adult mouse brain. Proc. Natl. Acad. Sci. USA, 79 (1978) 2722-2725.
5. [5] Birmanns, B., Saphier, D. and Abramsky, O., α-Interferon modifies cortical EEG activity: dose-dependence and antagonism by naloxone, J. Neurol. Sci., 100 (1990) 22-26.
6. [6] Bocci, V., Pauleus, L., Muscettola, M. and Viti, A., The physiologic interferons response. VI. Interferon activity in human plasma after a meal and drinking, Lymphokine Res., 4 (1985) 151-158.
7. [7] Bocci, V., What are the roles of interferons in physiological conditions? NIPS, 3 (1988) 201-203.
8. [8] Bocci, V., Physicochemical and biologic properties of interferons and their potential uses in drug delivery systems, Crit. Rev. Ther. Drug Carrier Syst., 9 (1992) 91-133.
9. [9] Dafny, N., Interferon modifies morphine withdrawal phenomena in rodents, Neuropharmacology, 22 (1983) 647-651.
10. [10] Dafny, N., Interferon modifies EEG and EEG-like activity recorded from sensory, motor, and limbic system structures in freely behaving rats, Neurotoxicology, 4 (1983) 235-240.
11. [11] Dafny, N., Interferon as a candidate endogenous substance preventing tolerance and dependence to brain opioids, Prog. Neuropsychopharmac. Biol. Psychiat., 8 (1984) 351-357.
12. [12] Dafny, N. and Gilman, S., Characterization of spontaneous unit activity in hypothalamus and reticular formation recorded with semimicoelectrodes, Brain Res., 59 (1973) 243-255.
13. [13] Dafny, N., Gilman, M.A. and Lichtigfeld, F.J., Cholecystokinin induced suppression of feeding in fed, fasting and hypothalamic island rats, Brain Res. Bull., 21 (1988) 225-231.
14. [14] Dafny, N., Lee, J.R. and Dougherty, P.M., Immune response products alter CNS activity: Interferon modulates central opioid function, J. Neurosci. Res., 19 (1988) 130-139.
15. [15] Dafny, N., Prieto-Gomez, B. and Reyes-Vazquez, C., Does the immune system communicate with the central nervous system? Interferon modifies central nervous system activity, J. Neuroimmunol., 9 (1985) 1-12.
16. [16] Dafny, N. and Reyes-Vazquez, C., Three different types of α-interferons alter naloxone-induced abstinence in morphine-addicted rats, Immunopharmacology, 9 (1985) 13-17.
17. [17] Dafny, N. and Reyes-Vazquez, C., Single injection of three different preparations of α-interferon modifies morphine abstinence signs for a prolonged period, Int. J. Neurosci., 32 (1987) 953-962.
18. [18] Darling, J.J., Hoyle, NR. and Thomas, D.G.T., Self and non-self in the brain, Immunol. Today, 2 (1981) 176-181.
19. [19] Dougherty, P.M., Aronowski, J., Samorajaski, T. and Dafny, N., Opiate antinociception is altered by immunomodification: the effect of interferon, cyclosporine and radiation-induced immune suppression upon acute and long-term morphine activity, Brain Res., 385 (1986) 401-404.
20. [20] Dougherty, P.M., Harper, C. and Dafny, N., The effect of alpha-interferon, cyclosporine A and radiation-immune suppression on morphine-induced hypothermia and tolerance, Life Sci., 39 (1986) 2191-2197.
21. [21] Farrar, W.L., Hill, J.M., Harel-Bellan, A. and Vinocour, M., The immune logical brain, Immunol. Rev., 100 (1987) 361-378.
22. [22] Fontana, A. and Fierz, W., The endothelium - Astrocytic immune control system of the brain, Springer Sem. Immunopathol., 8 (1985) 57-70.
23. [23] Hori, T., Nakashima, T., Take, S., Kaizuka, Y., Mori, T. and Katafuchi, T., Immune cytokines and regulation of body temperature, food intake and cellular immunity, Brain Res. Bull., 27 (1991) 309-313.
24. [24] Isaacs, A. and Lindenmann, J., Virus interference. I. The interferon, Proc. R. Soc. Lond. B, 147 (1957) 258-267.
25. [25] Kerr, F.W.L., Triplett, J.N. Jr. and Beeler, G.W., Reciprocal (push-pull) effects of morphine on single units in the ventromedian and lateral hypothalamus and influences on other nuclei: with a comment on methadone effects during withdrawal from morphine, Brain Res., 74 (1974) 81-103.
26. [26] Larsson, I., Landstrom, L.E., Larner, E., Lundgren, E., Miorner, H. and Strannegard, O., Interferon production in glia and glioma cell lines, Infect. Immun., 22 (1978) 786-789.
27. [27] Marcovitz, R., Tsiang, H. and Hovannesiam, A.G., Production and action of interferon in mice affected with rabies virus, Ann. Virol., 135E (1984) 19-33.
28. [28] Meyers, C.A. and Valentine, A.D., Neurological and psychiatric adverse effects of immunological therapy, CNS Drugs, 3 (1995) 56-68.
29. [29] Nakashima, T., Hori, T., Kuriyama, K. and Kiyohara, T., Naloxone blocks the interferon-α induced changes in hypothalamic neuronal activity, Neurosci. Lett., 82 (1987) 332-336.
30. [30] Nakashima, T., Hori, T., Kuriyama, K. and Matsuda, T., Effects of interferon-α on the activity of preoptic thermosensitive neurons in tissue slices, Brain Res., 454 (1988) 361-367.
31. [31] Ono, T., Oomura, Y., Nishino, H., Sasaki, K., Muramoto, K. and Yano, I. Morphine and enkephalin effects on hypothalamic glucosensitive neurons, Brain Res., 185 (1980) 208-212.
32. [32] Paxinos, G. and Watson, C., The Rat Brain, A Stereotaxic Atlas, Academic Press, Australia, 1986.
33. [33] Paulesu, L., Muscettola, M., Bocci, V. and Viti, A., Daily variations of plasma interferon levels in the rat, IRCS Med. Sci., 13 (1985) 993-994.
34. [34] Pavol, M.A., Meyers, C.A., Rexer, J.L., Valentine, A.D., Mattis, P.J. and Talpaz, M., Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia, Neurology, 45 (1995) 947-950.
35. [35] Pestka, S., Langer, J.A., Zoon, K.C. and Samuel, C.E., Interferons and their actions, Annu. Rev. Biochem., 56 (1987) 727-777.
36. [36] Plata-Salaman, C.R., Immunoregulators in the nervous system, Neurosci. Behav. Rev., 15 (1991) 185-215.
37. [37] Prieto-Gomez, B., Reyes-Vazquez, C. and Dafny, N., Differential effects of interferon on ventromedial hypothalamus and dorsal hippocampus, J. Neurosci. Res., 10 (1983) 273-278.
38. [38] Prieto-Gomez, B., Reyes-Vazquez, C. and Dafny, N., Microiontophoretic application of morphine and naloxone in rat hypothalamus neurons, Neuropharmacology, 23 (1981) 1081-1089.
39. [39] Reite, M., Laudenslager, M., Jones, J., Crnic, L. and Kaemingk, K., Interferon decreases REM latency, Biol. Psychiatry, 22 (1987) 104-107.
40. [40] Reyes-Vazquez, C., Prieto-Gomez, B. and Dafny, N., Alpha-interferon suppresses food intake and neuronal activity of the lateral hypothalamus, Neuropharmacology, 33 (1994) 1545-1552.
41. [41] Reyes-Vazquez, C., Prieto-Gomez, B., Georgiades, J.A. and Dafny, N., Alpha and gamma interferons effects on cortical and hippocampal neurons: microiontophoretic application and single cell recording, Int. J. Neurosci., 25 (1984) 113-121.
42. [42] Saphier, D., Kidron, D., Ovadia, H., Weidenfeld, J., Abramsky, O., Burstein, Y., Pecht, M. and Trainin, N., Preoptic area (POA) multiunit activity (MUA) and cortical EEG changes following intracerebroventricular (i.c.v.) administration of α-interferon (INF), thymic humoral factor (THF), histamine (HIS), and interleukin-1 (IL-1), Rev. Clin. Basic Pharmacol., 6 (1987) 265-278.
43. [43] Saphier, D., Roerig, S.C., Ito, C., Vlasak, W.R., Farrar, G.E., Broyles, J.E. and Welch, J.E., Inhibition of neural and neuroendocrine activity by α-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat, Brain Behav. Immun., 8 (1994) 37-56.
44. [44] Smedley, H., Katrak, M., Sikora, K. and Wheeler, T., Neurological effects of recombinant human interferon, Br. Med. J., 286 (1983) 262-264.
45. [45] Zar, J.H., Biostatistical Analysis, Prentice-Hall, NY, 1984.